Cleavage of factor XIII by human neutrophil elastase results in a novel active truncated form of factor XIII A subunit

Thrombosis and Haemostasis

Volumn 99, Issue 4, 2008, Pages 668-674

  Bagoly, Zsuzsa ^a   Fazakas, Ferenc ^a   Komáromi, István ^a   Haramura, Gizella ^a   Tóth, Eszter ^a   Muszbek, László ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Elastase; Factor XIII; Factor XIII A V34L polymorphism; Transglutaminase

Indexed keywords

AMINO ACID; BATROXOBIN; BATROXOBIN MOOJENI; BLOOD CLOTTING FACTOR 13A; BLOOD CLOTTING FACTOR 8; FIBRIN; LEUKOCYTE ELASTASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; THROMBIN; VALINE;

ALPHA CHAIN; ARTICLE; CROSS LINKING; DEGRADATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BINDING; FRAGMENTATION REACTION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; WESTERN BLOTTING;

AMINO ACID SEQUENCE; BINDING SITES; BLOTTING, WESTERN; CROSS-LINKING REAGENTS; FACTOR XIII; FACTOR XIIIA; FIBRIN; HUMANS; KINETICS; LEUKOCYTE ELASTASE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION; PROTEIN SUBUNITS;

EID: 43749101177     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-09-0577     Document Type: Article

References (43)

1. Muszbek L, Yee VC, Hevessy Z. Blood coagulation factor XIII: structure and function. Thromb Res 1999; 94: 271-305.
2. th edn. Philadelphia: Lippincott Williams and Wilkins, 2006: 153-181.
3. Wartiovaara U, Mikkola H, Szôke G, et al. Effect of Val34Leu polymorphism on the activation of the coagulation factor XIII-A. Thromb Haemost 2000; 84: 595-600.
4. Ariens RA, Philippou H, Nagaswami C, et al. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood 2000; 96: 988-995.
5. Balogh I, Szôke G, Kárpáti L, et al. Val34Leu polymorphism of plasma FXIII: biochemistry and epidemiology in familial thrombophilia. Blood 2000; 96: 2479-2486.
6. Walter M, Nyman D, Krajnc V, et al. The activation of plasma factor XIII with the snake venom enzymes ancrod and batroxobin marajoensis. Thromb Haemost 1977; 38: 438-446.
7. Niewiarowski S, Kirby EP, Brudzynski TM, et al. Thrombocytin, a serine protease from Bothrops atrox venom. 2. Interaction with platelets and plasma-clotting factors. Biochemistry 1979; 18: 3570-3577.
8. Kopec M, Latallo ZS, Stahl M, et al. The effect of proteolytic enzymes on fibrin stabilizing factor. Biochim Biophys Acta 1969; 181: 437-445.
9. Schwartz ML, Pizzo SV, Hill RL, et al. Human factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin. J Biol Chem 1973; 248: 1395-1407.
10. McDonagh J, McDonagh RP. Alternative pathways for the activation of factor XIII. Br J Haematol 1975; 30: 465-477.
11. Dall'Acqua W, Halin C, Rodrigues ML, et al. Elastase substrate specificity tailored through substrate-assisted catalysis and phage display. Protein Eng 1999; 12: 981-987.
12. Harris JL, Backes BJ, Leonetti F, et al. Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries. Proc Natl Acad Sci USA 2000; 97: 7754-7759.
13. Koehl C, Knight CG, Bieth JG. Compared action of neutrophil proteinase 3 and elastase on model substrates. J Biol Chem 2003; 278: 12609-12612.
14. Kawabata K, Suzuki M, Sugitani M, et al. ONO-5046, a novel inhibitor of human neutrophil elastase. Biochem Biophys Res Commun 1991; 177: 814-820.
15. Lorand L, Credo RB, Janus TG. Factor XIII (fibrin stabilizing factor). Methods Enzymol 1981; 80: 333-341.
16. Polgár J, Hidasi V, Muszbek L. Non-proteolytic activation of cellular protransglutaminase (placental macrophage factor XIII). Biochem J 1990; 267: 557-560.
17. Shemirani AH, Muszbek L. Rapid detection of the factor XIII Val34Leu (163 G->T) polymorphism by real-time PCR using fluorescence resonance energy transfer detection and melting curve analysis. Clin Chem Lab Med 2004; 42: 877-879.
18. Kárpáti L, Penke B, Katona E, et al. A modified, optimized kinetic photometric assay for the determination of blood coagulation factor XIII activity in plasma. Clin Chem 2000; 46: 1946-1955.
19. Siebenlist KR, Meh DA, Mosesson MW. Protransglutaminase (Factor XIII) mediated crosslinking of fibrinogen and fibrin. Thromb Haemost 2001; 86: 1221-1228.
20. Hunkapiller MW, Hewick RM, Dreyer WJ, Hood LE. High-sensitivity sequencing with a gas-phase sequenator. Methods Enzymol 1983; 91: 399-413.
21. Weiss MS, Metzner HJ, Hilgenfeld R. Two non-proline cis peptide bonds may be important for factor XIII function. FEBS Letters 1998; 423: 291-296.
22. Humphrey W, Dalke A, Schulten K. VMD - Visual Molecular Dynamics. J Molec Graphics 1996; 14: 33-38.
23. Hornyak TJ, Shaffer JA. Role of calcium ion in the generation of factor XIII activity. Biochemistry 1991; 30: 6175-6182.
24. Stocker K. Application of snake venom proteins in the diagnosis of hemostatic disorders. In: Stocker K ed. Medical use of snake venom proteins. Boca Raton: CRC-Press, 1990: 213-252.
25. Holleman WH, Weiss LJ. The thrombin-like enzyme from Bothrops atrox snake venom. J Biol Chem 1976; 251: 1663-1669.
26. Schmidt W, Egbring R, Havemann K. Effect of elastase-like and chymotrpysin-like neutral proteases from human granulocytes on isolated clotting factors. Thromb Res 1975; 5: 315-326.
27. Klingemann HG, Egbring R, Holst F, et al. Degradation of human plasma fibrin stabilizing factor XIII subunits by human granulocytic proteinases. Thromb Res 1982; 25: 793-801.
28. Henriksson P, Nilsson IM, Ohlsson K, et al. Granulocyte elastase activation and degradation of factor XIII. Thromb Res 1980; 18: 343-351.
29. Radek JT, Jeong JM, Wilson J, et al. Association of A subunits of recombinant placental factor XIII with the native carrier B subunits from human plasma. Biochemistry 1993; 32: 3527-3534.
30. Lorand L, Jeong JM, Radek JT, et al. Human plasma factor XIII: Subunit interactions and activation of zymogen. Methods Enzymol 1993; 222: 22-35.
31. Yee VC, Pedersen LC, Bishop PD, et al. Structural evidence that the activation peptide is not released upon thrombin cleavage of factor XIII. Thromb Res 1995; 78: 389-397.
32. Schroeder V, Vuissoz J, Caflisch A, et al. Factor XIII activation peptide is released into plasma upon cleavage by thrombin and shows a different structure compared to its bound form. Thromb Haemost 2007; 97: 890-898.
33. Samis JA, Garrett M, Manuel RP, et al. Human neutrophil elastase activates human factor V but inactivates thrombin-activated human factor V. Blood 1997; 90: 1065-1074.
34. Machovich R, Owen WG. The elastase-mediated pathway of fibrinolysis. Blood Coag Fibrinol 1990; 1: 79-90.
35. 2). Thromb Haemost 2000; 83: 268-273.
36. Wiedow O, Muehle K, Sreit V, et al. Human eosinophils lack human leukocyte elastase. Biochim Biophys Acta 1996; 1315: 185-187.
37. Falanga A, Marchetti M, Evangelista V, et al. Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera. Blood 2000; 96: 4261-4266.
38. Wiedow O, Meyer-Hoffert U. Neutrophil serine proteases: potential key regulators of cell signalling during inflammation. J Int Med 2005; 257: 319-328.
39. Abrams WR, Diamond LW, Kane AB. A flow cytometric assay of neutrophil degranulation. J Histochem Cytochem 1983; 31: 737-744.
40. Achyuthan KE. Characterization of the reciprocal binding sites on human α-thrombin and factor XIII A-chain. Mol Cel Biochem 1998; 178: 289-297.
41. Bagoly Z, Haramura G, Muszbek L. Down-regulation of activated factor XIII by polymorphonuclear granulocyte proteases within fibrin clot. Thromb Haemost 2007; 98: 359-367.
42. Spencer LT, Paone G, Krein PM, et al. Role of human neutrophil peptides in lung inflammation associated with α1-antitrypsin deficiency. Am J Physiol Lung Cell Mol Physiol 2004; 286: L514-520.
43. Katona É, Nagy B, Kappelmayer J, et al. Factor XIII in bronchoalveolar lavage fluid from children with chronic bronchoalveolar inflammation. J Throm Haemost 2005; 3: 1407-1413.